← Alle mensen

ME

Moshe E Gatt

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma:...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2026

A phase 2 gerandomiseerde study of modakafusp alfa as a single agent for patiënten met relapsed/refractory multiple m...

Blood · 28 augustus 2025

Belantamab mafodotin plus bortezomib and dexamethasone in patiënten met relapsed or refractory multiple myeloma (DREA...

The Lancet. Oncology · 2025-08

Belantamab mafodotin plus bortezomib-dexamethason bij myeloom: DREAMM-7 fase III

The New England journal of medicine · 1 augustus 2024

Selinexor-bortezomib-dexamethason versus bortezomib-dexamethason bij recidief myeloom: BOSTON fase III

Lancet (London, England) · 14 november 2020